Creating a vaccine to protect against all COVID-19 variants
Official title: Development of a Pan-COVID-19 Vaccine Candidate
Funded at RNA Therapeutics INC. · NIH-10819607 · Data updated 2026-11-12
This study is working on a new COVID-19 vaccine that hopes to protect against different strains of the virus, including new ones, using a special technology that has been successful before, and it's designed to help your body build a strong defense against future infections.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | RNA Therapeutics INC. NIH-funded |
| Lab location | 1 site (Newark, UNITED STATES) |
| Project start | March 13, 2024 |
| Project end | February 28, 2026 |
| Funding year | 2024 |
| Award (this year) | $299,967 |
| NIH project number | 1R41AI181134-01 |
| Project ID | NIH-10819607 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals who are at risk of COVID-19 infection, including those with underlying health conditions or those in high-exposure environments.
✕Less likely to help
Patients who are already fully vaccinated with existing COVID-19 vaccines may not receive additional benefit from this research.
What this research studies
This research focuses on developing a pan-COVID-19 vaccine that aims to provide broad protection against various strains of the virus, including emerging variants. The approach utilizes mRNA technology, which has shown promise in previous vaccine developments. The vaccine candidate expresses a conserved protein from the virus, which has demonstrated strong immune responses in animal studies. By targeting a more stable part of the virus, the goal is to enhance immunity and reduce the risk of future outbreaks.
Why it matters
Potential benefit: If successful, this research could lead to a more effective vaccine that protects against multiple COVID-19 variants, potentially reducing hospitalizations and deaths.
How similar studies have gone: Other research has shown success with mRNA vaccine technology, particularly in the rapid development of COVID-19 vaccines, indicating a promising avenue for this novel approach.
Where this research is happening
-
RNA Therapeutics INC.
Newark, United States Active
Researchers
- Principal investigator: Hu, Haitao — RNA Therapeutics INC.
- Study coordinator: Hu, Haitao
Related research
Other NIH-funded projects on the same topics.
-
Structural factors linking minimum wage, COVID-19, and community violence
A long-term study will explore whether higher minimum wages and pandemic-related economic factors are connected to changes in violence in US communities.
-
COVID-19 healthcare disruptions and heart health inequities in NYC adults with multiple conditions
This project looks at how COVID-19-related gaps in care affected heart health in adults with several chronic conditions in New York City.
-
Modifying body fat to aid COVID-19 recovery through behavioral strategies
A study in veterans explores whether changing weight through lifestyle habits can improve recovery after COVID-19–related health problems.
-
Post-COVID Neuro-Cognitive Changes in Older African Americans
A study explores how COVID-19 affects thinking, memory, and daily life in older African American adults and what might be driving these changes.
-
How COVID school closures affected kids with or at risk for developmental differences
This NIH grant follows children aged 4 to 15 and their families to see how pandemic school closures impacted emotional well-being and parenting over three years.
-
Long-term COVID-19 effects in older Veterans and a rehabilitation approach
This project looks at how COVID-19 affects blood vessel health in older Veterans and tests a rehab strategy together with a mitochondria-targeted antioxidant to help recovery.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.